Attachment: Extract from Clinical Evaluation Obinutuzumab

Prior to the initiation of the study, each site chose one of three chemotherapy regimens (CHOP, CVP, or bendamustine) that was considered to be the standard of care for follicular lymphoma; all patients with follicular lymphoma at that site received the chosen chemotherapy regimen for the duration of the study (a site could switch to another ... ................
................